Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD200R agonist antibodies and uses thereof

CD200R agonist antibodies and uses thereof

US Patent 11319370 · Granted May 3, 2022

Estimated economic value: $1,907,778,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Picture frame2024
PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa2024
IgG bispecific antibodies and processes for preparation2024
Bispecific antibodies targeting immune checkpoints2024
Human interleukin-4 receptor alpha antibodies2024
Methods for producing fabs and IgG bispecific antibodies2023
Pan-ELR+ CXC chemokine antibodies2020
IgG bispecific antibodies and processes for preparation2020
Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof2020
Anti-CGRP/anti-IL-23 bispecific antibodies and uses thereof2020
Methods for producing Fabs and bi-specific antibodies2020
Methods for producing Fabs and bi-specific antibodies2020